TRECONDYV
Google image searchProduct monograph
Active ingredient
treosulfan, 5 G/VIAL
DIN: 02517388
Dosage form(s): POWDER
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: MEDEXUS PHARMACEUTICALS INC.
Date: 31-AUG-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01A — ALKYLATING AGENTS (ATC, ATC/DDD)
- L01AB — Alkyl sulfonates (ATC, ATC/DDD)
- L01AB02 — TREOSULFAN (ATC/DDD)
Reference brand drug: Trecondyv
